CD274 and breast carcinoma: We further re-expressed B4GALT1 in RBMS1-depleted breast cancer cells, and found that re-expression of B4GALT1 rescued RBMS1 depletion-induced decrease of PD-L1 glycosylation (Figs. 4E and S7).